Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with

Behaviour and Behaviour Mechanisms Epilepsy Genetic Counselling Paediatrics Psychiatry

Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
14 Aug 2023
Historique:
received: 14 11 2022
accepted: 27 07 2023
pubmed: 15 8 2023
medline: 15 8 2023
entrez: 14 8 2023
Statut: aheadofprint

Résumé

Pathogenic variants in the zinc finger protein coding genes are rare causes of intellectual disability and congenital malformations. Mutations in the As a result of an international collaboration using GeneMatcher Phenome Central Repository and personal communications, here we describe the clinical and molecular genetic characteristics of 22 previously unreported individuals. The core clinical phenotype is characterised by developmental delay particularly in the domain of speech development, postnatal growth retardation, microcephaly and facial dysmorphism. Corpus callosum abnormalities appear less frequently than suggested by previous observations. The identified mutations concerned nonsense or frameshift variants that were mainly located in the last exon of the The GDACCF syndrome is clinically diverse, and a genotype-first approach, that is, exome sequencing is recommended for establishing a genetic diagnosis rather than a phenotype-first approach. However, the syndrome may be suspected based on some recurrent, recognisable features. Corpus callosum anomalies were not as constant as previously suggested, we therefore recommend to replace the term 'GDACCF syndrome' with '

Sections du résumé

BACKGROUND BACKGROUND
Pathogenic variants in the zinc finger protein coding genes are rare causes of intellectual disability and congenital malformations. Mutations in the
METHODS METHODS
As a result of an international collaboration using GeneMatcher Phenome Central Repository and personal communications, here we describe the clinical and molecular genetic characteristics of 22 previously unreported individuals.
RESULTS RESULTS
The core clinical phenotype is characterised by developmental delay particularly in the domain of speech development, postnatal growth retardation, microcephaly and facial dysmorphism. Corpus callosum abnormalities appear less frequently than suggested by previous observations. The identified mutations concerned nonsense or frameshift variants that were mainly located in the last exon of the
CONCLUSION CONCLUSIONS
The GDACCF syndrome is clinically diverse, and a genotype-first approach, that is, exome sequencing is recommended for establishing a genetic diagnosis rather than a phenotype-first approach. However, the syndrome may be suspected based on some recurrent, recognisable features. Corpus callosum anomalies were not as constant as previously suggested, we therefore recommend to replace the term 'GDACCF syndrome' with '

Identifiants

pubmed: 37580113
pii: jmg-2022-109030
doi: 10.1136/jmg-2022-109030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Katalin Szakszon (K)

Faculty of Medicine Institute of Pediatrics, University of Debrecen, Debrecen, Hungary szakszon.katalin@med.unideb.hu.
Rare Congenital Malformations and Rare intellectual Disability (ERN ITHACA), European Reference Networks, Debrecen, Hungary.

Charles Marques Lourenco (CM)

Neurogenetics Unit - Inborn Errors of Metabolism Clinics, National Reference Center for Rare Diseases, Medicine School of Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil.

Bert Louis Callewaert (BL)

Center for Medical Genetics, University Hospital Ghent, Gent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

David Geneviève (D)

Montpellier University, Inserm Unit U1183, Reference Center for Rare Disease: Developmental Anomalies. Clinical Genetic Unit, CHU Montpellier, Montpellier, France.
Rare Congenital Malformations and Rare Intellectual Disability (ERN ITHACA), European Reference Networks, Montpellier, France.

Flavien Rouxel (F)

Génétique Clinique, Départment de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CHU Montpellier, Montpellier University, Centre de Référence Anomalies du Développement SOOR, Montpellier, France.

Denis Morin (D)

Rare Kidney Disease Center, Montpellier University Hospital, Montpellier, France.

Anne-Sophie Denommé-Pichon (AS)

Functional Unity of Innovative Diagnosis for Rare Diseases, University of Burgundy, Dijon, France.
Inserm UMR1231 team GAD, University of Burgundy, Dijon, France.

Antonio Vitobello (A)

Functional Unity of Innovative Diagnosis for Rare Diseases, University of Burgundy, Dijon, France.
Inserm UMR1231 team GAD, University of Burgundy, Dijon, France.

Wesley G Patterson (WG)

Greenwood Genetic Center Foundation, Greenwood, South Carolina, USA.

Raymond Louie (R)

Greenwood Genetic Center Inc, Greenwood, South Carolina, USA.

Filippo Pinto E Vairo (F)

Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.

Eric Klee (E)

Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.

Charu Kaiwar (C)

Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.

Ralitza H Gavrilova (RH)

Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.

Katherine E Agre (KE)

Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.

Sebastien Jacquemont (S)

Sainte-Justine Research Center, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Department of Medical Genetics, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.

Jizi Khadijé (J)

Department of Medical Genetics, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.

Jacques Giltay (J)

Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.

Koen van Gassen (K)

Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Gabriella Merő (G)

Faculty of Medicine Institute of Pediatrics, University of Debrecen, Debrecen, Hungary.

Erica Gerkes (E)

University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

Bregje W Van Bon (BW)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Tuula Rinne (T)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Rolph Pfundt (R)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Han G Brunner (HG)

Klinische Genetica, Maastricht University Medical Centre, Maastricht, The Netherlands.

Oana Caluseriu (O)

Medical Genetics Clinic, University of Alberta, Edmonton, Alberta, Canada.

Ute Grasshoff (U)

Institute of Medical Genetics and Applied Genomics, University Clinic, Tübingen University, Tübingen, Germany.

Martin Kehrer (M)

Institute of Medical Genetics and Applied Genomics, University Clinic, Tübingen University, Tübingen, Germany.

Tobias B Haack (TB)

Institute of Medical Genetics and Applied Genomics, University Clinic, Tübingen University, Tübingen, Germany.

Melik Malek Khelifa (MM)

Department of Human Genetics, Medical College Hannover, Hannover, Germany.

Anke Katharina Bergmann (AK)

Department of Human Genetics, Hannover Medical School, Hannover, Germany.

Anna Maria Cueto-González (AM)

Department of Clinical and Molecular Genetics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Rare Congenital Malformations and Rare intellectual Disability (ERN ITHACA), European Reference Networks, Barcelona, Spain.

Ariadna Campos Martorell (AC)

Pediatric Endocrinology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Endocrinology Group, Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Vall d'Hebron Research Institute, Barcelona, Spain.

Shwetha Ramachandrappa (S)

Clinical Genetics Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.

Lindsey B Sawyer (LB)

Department of Medical Genetics, Children's Hospital of The King's Daughters, Norfolk, Virginia, USA.

Pascale Fasel (P)

Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland.

Dominique Braun (D)

Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland.

Atallah Isis (A)

Division of Genetic Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Andrea Superti-Furga (A)

Division of Genetic Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Vanda McNiven (V)

University Health Network and Mount Sinai Hospital, Fred A Litwin Family Centre in Genetic Medicine, Toronto, Ontario, Canada.
Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

David Chitayat (D)

Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, Ontario, Canada.

Syed Anas Ahmed (SA)

University Health Network and Mount Sinai Hospital, Fred A Litwin Family Centre in Genetic Medicine, Toronto, Ontario, Canada.

Heiko Brennenstuhl (H)

Insittute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Eva Mc Schwaibolf (EM)

Insittute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Gladys Battisti (G)

Centre de Génétique Humaine, Institut de Pathologie et de Genetique asbl, Gosselies, Belgium.

Benoit Parmentier (B)

Centre de Génétique Humaine, Institut de Pathologie et de Genetique asbl, Gosselies, Belgium.

Servi J C Stevens (SJC)

Klinische Genetica, Maastricht University Medical Center, Maastricht, The Netherlands.

Classifications MeSH